marketcaparena
Search

    RXRX

    RECURSION PHARMACEUTICALS, INC.

    Company overview

    Market capitalization
    $1.98B
    Employees
    600
    Latest publication
    2026-09-29
    About RECURSION PHARMACEUTICALS, INC.

    Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20212021-12-31 · USDQ1 20212021-03-31 · USDQ4 20202020-12-31 · USDQ2 20202020-06-30 · USDQ1 20202020-03-31 · USD
    Total Revenue7,670,000USD2,500,000USD2,500,000USD2,551,000USD186,000USD60,000USD
    Cost Of Revenue11,491,000USD2,576,000USD24,109,000USD20,698,000USD13,244,000USD12,842,000USD
    Gross Profit-3,821,000USD2,500,000USD2,500,000USD2,551,000USD-13,058,000USD-12,782,000USD
    Research Development89,614,000USD48,292,000USD24,109,000USD20,698,000USD13,244,000USD12,842,000USD
    General And Administrative Expenses41,533,000USD—————
    Total Operating Expenses131,147,000USD67,460,000USD32,984,000USD28,132,000USD18,217,000USD18,343,000USD
    Operating Income-134,968,000USD-64,960,000USD-30,484,000USD-25,581,000USD-18,217,000USD-18,343,000USD
    Total Other Income Expense Net3,962,000USD27,000USD-233,000USD-185,000USD-726,000USD-81,000USD
    Income Before Tax-131,006,000USD-64,933,000USD-30,717,000USD-25,766,000USD-18,943,000USD-18,424,000USD
    Income Tax Expense-1,000USD19,000USD233,000USD-484,000USD726,000USD81,000USD
    Net Income-131,005,000USD-64,933,000USD-30,717,000USD-25,766,000USD-18,943,000USD-18,424,000USD
    Selling General Administrative—19,201,000USD8,937,000USD7,574,000USD5,159,000USD5,561,000USD
    Interest Income—21,000USD16,000USD46,000USD24,000USD220,000USD
    Interest Expense—2,000USD249,000USD231,000USD426,000USD301,000USD
    Net Interest Income—-2,000USD-233,000USD-185,000USD-402,000USD-81,000USD
    Net Income From Continuing Ops—-151,735,000USD-30,717,000USD-25,766,000USD-18,943,000USD-18,424,000USD
    Ebit—-64,933,000USD-30,468,000USD-25,535,000USD-18,517,000USD-18,123,000USD
    Ebitda—-62,357,000USD-29,066,000USD-23,911,000USD-17,493,000USD-17,186,000USD
    Depreciation And Amortization—2,576,000USD1,402,000USD1,624,000USD1,024,000USD937,000USD
    Reconciled Depreciation—2,236,000USD1,402,000USD1,624,000USD1,024,000USD937,000USD
    Non Operating Income Net Other—-2,678,000USD————
    Net Income Applicable To Common Shares—-64,933,000USD-30,717,000USD—-18,943,000USD-18,424,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Revenue10,000,000USD3,413,000USD1,711,000USD
    Cost Of Revenue9,104,000USD63,319,000USD45,809,000USD
    Gross Profit10,000,000USD3,413,000USD-44,098,000USD
    Research Development135,271,000USD63,319,000USD45,809,000USD
    Selling General Administrative57,682,000USD25,258,000USD18,951,000USD
    Total Operating Expenses192,775,000USD88,028,000USD64,152,000USD
    Operating Income-182,775,000USD-84,615,000USD-62,441,000USD
    Interest Income73,000USD336,000USD1,741,000USD
    Interest Expense2,952,000USD1,360,000USD635,000USD
    Net Interest Income-2,879,000USD-1,024,000USD1,106,000USD
    Income Before Tax-186,479,000USD-87,006,000USD-61,879,000USD
    Income Tax Expense-8,405,000USD876,000USD646,000USD
    Tax Provision0USD——
    Net Income-178,074,000USD-87,006,000USD-62,525,000USD
    Net Income From Continuing Ops-186,479,000USD-87,006,000USD-61,879,000USD
    Ebit-182,775,000USD-85,646,000USD-61,879,000USD
    Ebitda-174,370,000USD-81,703,000USD-58,336,000USD
    Depreciation And Amortization8,405,000USD3,943,000USD3,543,000USD
    Reconciled Depreciation8,405,000USD4,442,000USD3,543,000USD
    Total Other Income Expense Net-3,704,000USD-2,391,000USD562,000USD
    Non Operating Income Net Other-3,704,000USD——
    Net Income Applicable To Common Shares-186,479,000USD-87,006,000USD-61,879,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,212,668,000USD1,339,522,000USD1,474,130,000USD1,399,526,000USD1,302,355,000USD1,305,234,000USD1,448,598,000USD726,499,000USD
    Cash And Equivalents545,683,000USD———————
    Total Current Assets603,462,000USD709,557,000USD812,845,000USD714,105,000USD587,160,000USD584,145,000USD714,269,000USD474,172,000USD
    Other Current Assets29,321,000USD41,499,000USD44,902,000USD32,359,000USD37,338,000USD37,568,000USD70,753,000USD44,270,000USD
    Other Non Current Assets12,186,000USD———————
    Total Liabilities297,665,000USD———————
    Total Current Liabilities119,886,000USD129,699,000USD147,707,000USD155,103,000USD164,026,000USD141,981,000USD187,472,000USD108,888,000USD
    Other Current Liabilities56,936,000USD———————
    Other Non Current Liabilities2,702,000USD———————
    Total Stockholder Equity915,003,000USD1,024,769,000USD1,130,865,000USD1,046,948,000USD919,146,000USD933,947,000USD1,034,782,000USD524,559,000USD
    Total Equity Including Noncontrolling Interest915,003,000USD———————
    Long Term Debt4,753,000USD7,181,000USD9,564,000USD11,902,000USD14,196,000USD16,446,000USD19,022,000USD20,510,000USD
    Deferred Revenue27,586,000USD———————
    Deferred Revenue Non Current112,818,000USD———————
    Property Plant Equipment Net129,894,000USD157,321,000USD169,480,000USD181,244,000USD193,604,000USD204,777,000USD233,213,000USD159,189,000USD
    Goodwill160,350,000USD———————
    Intangible Assets282,888,000USD294,073,000USD309,903,000USD322,344,000USD341,319,000USD335,790,000USD335,855,000USD34,093,000USD
    Accounts Payable12,672,000USD20,348,000USD18,118,000USD13,935,000USD19,314,000USD25,086,000USD21,613,000USD2,260,000USD
    Short Term Debt13,249,000USD22,352,000USD21,754,000USD20,444,000USD20,484,000USD20,440,000USD22,220,000USD16,452,000USD
    Common Stock5,000USD5,000USD5,000USD5,000USD4,000USD4,000USD4,000USD3,000USD
    Retained Earnings-2,324,511,000USD-2,193,506,000USD-2,076,002,000USD-1,967,879,000USD-1,805,589,000USD-1,633,694,000USD-1,431,283,000USD-1,252,377,000USD
    Accumulated Other Comprehensive Income27,994,000USD26,662,000USD36,717,000USD34,093,000USD43,620,000USD14,145,000USD-7,637,000USD—
    Total Liab—314,753,000USD343,265,000USD352,578,000USD383,209,000USD371,287,000USD413,816,000USD201,940,000USD
    Other Current Liab—54,205,000USD70,230,000USD73,360,000USD84,538,000USD56,804,000USD81,872,000USD40,597,000USD
    Capital Stock—5,000USD5,000USD5,000USD4,000USD4,000USD4,000USD3,000USD
    Good Will—160,170,000USD162,158,000USD162,042,000USD164,270,000USD158,112,000USD148,873,000USD52,056,000USD
    Cash—654,473,000USD743,294,000USD659,836,000USD528,216,000USD500,453,000USD594,350,000USD427,647,000USD
    Cash And Short Term Investments—654,473,000USD743,294,000USD659,836,000USD528,216,000USD500,453,000USD594,350,000USD427,647,000USD
    Current Deferred Revenue—32,794,000USD37,605,000USD47,364,000USD39,690,000USD39,651,000USD61,767,000USD49,579,000USD
    Net Debt—-582,098,000USD-665,329,000USD-577,462,000USD-440,141,000USD-407,543,000USD-485,858,000USD-337,022,000USD
    Short Long Term Debt—9,265,000USD9,091,000USD8,919,000USD8,752,000USD8,587,000USD8,425,000USD8,219,000USD
    Short Long Term Debt Total—72,375,000USD77,965,000USD82,374,000USD88,075,000USD92,910,000USD108,492,000USD90,625,000USD
    Net Receivables—13,585,000USD24,649,000USD21,910,000USD21,606,000USD46,124,000USD49,166,000USD2,255,000USD
    Property Plant Equipment Gross—157,321,000USD258,694,000USD181,244,000USD193,604,000USD204,777,000USD295,884,000USD215,656,000USD
    Common Stock Shares Outstanding—529,303,984shares526,719,743shares446,988,046shares417,361,147shares402,772,000shares336,036,000shares282,583,048shares
    Non Current Assets Total—629,965,000USD661,285,000USD685,421,000USD715,195,000USD721,089,000USD734,329,000USD252,327,000USD
    Non Current Liabilities Total—185,054,000USD195,558,000USD197,475,000USD219,183,000USD229,306,000USD226,344,000USD93,052,000USD
    Non Current Liabilities Other—2,025,000USD2,080,000USD1,029,000USD1,565,000USD4,790,000USD4,732,000USD2,999,000USD
    Non Currrent Assets Other—17,444,000USD18,787,000USD18,834,000USD9,416,000USD20,407,000USD14,454,000USD6,989,000USD
    Net Working Capital—579,858,000USD665,138,000USD559,002,000USD423,134,000USD442,164,000USD526,797,000USD365,284,000USD
    Unclassified Current Liabilities—-9,265,000USD-9,091,000USD-8,919,000USD-8,752,000USD-8,587,000USD-8,425,000USD-8,219,000USD
    Unclassified Non Current Liabilities—175,848,000USD183,914,000USD184,544,000USD203,422,000USD208,070,000USD202,590,000USD69,543,000USD
    Unclassified Equity—3,191,603,000USD3,170,140,000USD2,980,724,000USD2,681,107,000USD2,553,488,000USD2,473,694,000USD1,776,930,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets1,474,130,000USD1,448,598,000USD653,699,000USD701,288,000USD610,345,000USD298,585,000USD101,431,000USD
    Intangible Assets309,903,000USD335,855,000USD36,443,000USD1,306,000USD1,385,000USD1,689,000USD—
    Other Current Assets44,902,000USD70,753,000USD43,478,000USD17,149,000USD9,066,000USD4,155,000USD6,364,000USD
    Total Liab343,265,000USD413,816,000USD190,263,000USD215,482,000USD67,407,000USD504,874,000USD225,696,000USD
    Total Stockholder Equity1,130,865,000USD1,034,782,000USD463,436,000USD485,806,000USD542,938,000USD-206,289,000USD-124,265,000USD
    Other Current Liab70,230,000USD81,872,000USD46,635,000USD32,904,000USD32,333,000USD10,207,000USD4,587,000USD
    Common Stock5,000USD4,000USD2,000USD2,000USD2,000USD——
    Capital Stock5,000USD4,000USD2,000USD2,000USD2,000USD0USD0USD
    Retained Earnings-2,076,002,000USD-1,431,283,000USD-967,622,000USD-639,556,000USD-400,080,000USD-213,601,000USD-126,595,000USD
    Good Will162,158,000USD148,873,000USD52,056,000USD801,000USD801,000USD801,000USD—
    Cash743,294,000USD594,350,000USD391,565,000USD549,912,000USD285,116,000USD262,126,000USD69,883,000USD
    Cash And Short Term Investments743,294,000USD594,350,000USD391,565,000USD549,912,000USD516,562,000USD262,126,000USD69,883,000USD
    Total Current Assets812,845,000USD714,269,000USD438,137,000USD569,814,000USD534,718,000USD266,437,000USD76,398,000USD
    Total Current Liabilities147,707,000USD187,472,000USD93,171,000USD100,265,000USD46,658,000USD23,099,000USD6,684,000USD
    Current Deferred Revenue37,605,000USD61,767,000USD36,426,000USD56,726,000USD10,000,000USD10,000,000USD—
    Net Debt-665,329,000USD-485,858,000USD-340,893,000USD-498,907,000USD-273,638,000USD-246,464,000USD-53,714,000USD
    Short Term Debt21,754,000USD22,220,000USD6,157,000USD6,049,000USD1,506,000USD1,540,000USD544,000USD
    Short Long Term Debt9,091,000USD8,425,000USD41,000USD97,000USD90,000USD1,073,000USD77,000USD
    Short Long Term Debt Total77,965,000USD108,492,000USD50,672,000USD51,005,000USD11,478,000USD15,662,000USD16,169,000USD
    Long Term Debt9,564,000USD19,022,000USD1,101,000USD536,000USD633,000USD11,414,000USD12,418,000USD
    Net Receivables24,649,000USD49,166,000USD3,094,000USD2,753,000USD9,090,000USD156,000USD151,000USD
    Accounts Payable18,118,000USD21,613,000USD3,953,000USD4,586,000USD2,819,000USD1,074,000USD1,261,000USD
    Property Plant Equipment Net169,480,000USD233,213,000USD120,173,000USD121,447,000USD64,725,000USD25,967,000USD24,370,000USD
    Property Plant Equipment Gross258,694,000USD295,884,000USD165,045,000USD121,447,000USD83,462,000USD25,967,000USD24,370,000USD
    Accumulated Other Comprehensive Income36,717,000USD-7,637,000USD0USD0USD-126,000USD-9,962,000USD-5,715,000USD
    Common Stock Shares Outstanding447,446,109shares274,207,000shares207,853,702shares175,537,487shares170,272,462shares165,791,490shares165,791,490shares
    Non Current Assets Total661,285,000USD734,329,000USD215,562,000USD131,474,000USD75,627,000USD32,148,000USD25,033,000USD
    Non Current Liabilities Total195,558,000USD226,344,000USD97,092,000USD115,217,000USD20,749,000USD481,775,000USD219,012,000USD
    Non Current Liabilities Other2,080,000USD4,732,000USD——16,006,000USD——
    Non Currrent Assets Other18,787,000USD8,825,000USD6,890,000USD7,920,000USD8,716,000USD3,691,000USD663,000USD
    Net Working Capital665,138,000USD526,797,000USD344,966,000USD469,549,000USD488,060,000USD246,379,000USD69,714,000USD
    Unclassified Current Liabilities-9,091,000USD-8,425,000USD—————
    Unclassified Non Current Liabilities183,914,000USD202,590,000USD95,991,000USD44,420,000USD-10,777,000USD451,020,000USD204,316,000USD
    Unclassified Equity3,170,140,000USD2,473,694,000USD1,431,054,000USD1,125,358,000USD943,140,000USD17,274,000USD8,045,000USD
    Unclassified Non Current Assets—7,563,000USD—-7,920,000USD-8,716,000USD——
    Other Assets——1USD7,920,000USD8,716,000USD650,000USD663,000USD
    Inventory——-3,094,000USD1,280,000USD1,552,000USD5,041,000USD5,288,000USD
    Other Liab———70,261,000USD10,777,000USD19,341,000USD2,278,000USD
    Short Term Investments———0USD231,446,000USD0USD—
    Net Tangible Assets———483,699,000USD540,752,000USD-208,779,000USD-124,265,000USD
    Deferred Long Term Liab————4,110,000USD——
    Unclassified Current Assets—————-5,041,000USD-5,288,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-117,504,000USD-108,122,000USD-162,253,000USD-171,897,000USD-202,487,000USD-178,906,000USD-95,842,000USD-97,540,000USD
    Depreciation19,673,000USD19,478,000USD21,043,000USD23,849,000USD19,331,000USD12,951,000USD7,198,000USD8,968,000USD
    Stock Based Compensation22,215,000USD23,763,000USD25,243,000USD26,159,000USD36,058,000USD30,784,000USD18,253,000USD16,524,000USD
    Other Non Cash Items6,917,000USD8,125,000USD24,903,000USD10,318,000USD20,993,000USD13,693,000USD11,430,000USD-2,837,000USD
    Change To Account Receivables14,746,000USD-836,000USD3,529,000USD25,407,000USD4,839,000USD-4,828,000USD-939,000USD736,000USD
    Change In Working Capital-7,805,000USD10,683,000USD-26,296,000USD35,153,000USD-5,852,000USD6,048,000USD-264,000USD-7,334,000USD
    Total Cash From Operating Activities-81,101,000USD-46,073,000USD-117,360,000USD-76,418,000USD-131,957,000USD-115,430,000USD-59,225,000USD-82,219,000USD
    Capital Expenditures-258,000USD-1,244,000USD-243,000USD-3,150,000USD-1,832,000USD-1,648,000USD-4,562,000USD-4,182,000USD
    Free Cash Flow-81,359,000USD-47,317,000USD-117,603,000USD-79,568,000USD-133,789,000USD-117,078,000USD-63,787,000USD-86,401,000USD
    Investments0USD0USD-2,549,000USD-5,808,000USD-7,270,000USD275,456,000USD-4,562,000USD-4,182,000USD
    Total Cashflows From Investing Activities-338,000USD-1,244,000USD-2,549,000USD-5,808,000USD-7,270,000USD275,456,000USD-4,562,000USD-4,182,000USD
    Net Borrowings-2,208,000USD-2,167,000USD-2,127,000USD-2,084,000USD-2,047,000USD-2,101,000USD-2,287,000USD—
    Total Cash From Financing Activities-3,470,000USD132,006,000USD251,340,000USD97,659,000USD40,527,000USD10,639,000USD16,462,000USD263,122,000USD
    Issuance Of Capital Stock0USD133,380,000USD254,460,000USD100,000,000USD41,024,000USD11,030,000USD16,968,000USD261,546,000USD
    Change In Cash-87,904,000USD86,776,000USD133,300,000USD24,688,000USD-93,867,000USD167,193,000USD-46,922,000USD176,603,000USD
    Begin Period Cash Flow747,888,000USD667,145,000USD533,845,000USD509,157,000USD603,024,000USD435,831,000USD482,753,000USD306,150,000USD
    End Period Cash Flow659,984,000USD753,921,000USD667,145,000USD533,845,000USD509,157,000USD603,024,000USD435,831,000USD482,753,000USD
    Other Cashflows From Investing Activities-80,000USD-1,244,000USD—-2,158,000USD-8,876,000USD-350,000USD-3,000,000USD-3,000,000USD
    Other Cashflows From Financing Activities-1,262,000USD132,006,000USD-993,000USD-3,000,000USD1,550,000USD1,710,000USD1,781,000USD1,602,000USD
    Unclassified Operating Cash Flow-4,597,000USD———————
    Unclassified Investing Cash Flow—1,244,000USD—5,308,000USD10,708,000USD—7,562,000USD7,182,000USD
    Unclassified Financing Cash Flow—-131,213,000USD—2,743,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income-644,759,000USD-463,661,000USD-328,066,000USD-239,476,000USD-87,006,000USD-61,879,000USD
    Depreciation83,701,000USD36,494,000USD24,402,000USD11,756,000USD3,943,000USD2,489,000USD
    Stock Based Compensation111,223,000USD81,688,000USD53,503,000USD27,909,000USD4,292,000USD1,385,000USD
    Other Non Cash Items64,339,000USD24,306,000USD6,638,000USD11,366,000USD2,538,000USD555,000USD
    Change To Account Receivables32,939,000USD-6,071,000USD-7,756,000USD-2,000USD-1,119,000USD605,000USD
    Change In Working Capital13,688,000USD-38,001,000USD-44,257,000USD104,921,000USD30,834,000USD408,000USD
    Total Cash From Operating Activities-371,808,000USD-359,174,000USD-287,780,000USD-83,524,000USD-45,399,000USD-57,042,000USD
    Capital Expenditures-6,469,000USD-13,695,000USD-11,955,000USD-37,359,000USD-6,735,000USD-3,910,000USD
    Free Cash Flow-378,277,000USD-372,869,000USD-300,332,000USD-120,883,000USD-52,134,000USD-60,952,000USD
    Investments-3,806,000USD260,059,000USD-15,719,000USD193,249,000USD-8,740,000USD-3,910,000USD
    Total Cashflows From Investing Activities-16,871,000USD260,059,000USD-10,228,000USD193,249,000USD-8,740,000USD-3,910,000USD
    Net Borrowings-8,425,000USD-4,440,000USD-766,000USD-90,000USD6,323,000USD705,000USD
    Total Cash From Financing Activities521,532,000USD304,120,000USD140,133,000USD154,345,000USD246,135,000USD120,410,000USD
    Issuance Of Capital Stock528,864,000USD300,417,000USD193,711,000USD143,711,000USD239,131,000USD119,915,000USD
    Change In Cash150,897,000USD201,599,000USD-157,687,000USD263,763,000USD191,996,000USD59,458,000USD
    Begin Period Cash Flow603,024,000USD401,425,000USD559,112,000USD295,349,000USD75,171,000USD15,713,000USD
    End Period Cash Flow753,921,000USD603,024,000USD401,425,000USD559,112,000USD267,167,000USD75,171,000USD
    Other Cashflows From Investing Activities-6,596,000USD-3,350,000USD-597,000USD-300,000USD-309,000USD595,000USD
    Other Cashflows From Financing Activities-3,000,000USD8,143,000USD12,806,000USD10,724,000USD239,812,000USD119,705,000USD
    Unclassified Investing Cash Flow—17,045,000USD18,043,000USD37,659,000USD7,044,000USD3,315,000USD
    Unclassified Financing Cash Flow——-65,618,000USD—-239,131,000USD-119,915,000USD
    Change To Inventory———2,000USD4,357,000USD—
    Change To Liabilities———112,087,000USD26,482,000USD-340,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductGrant367,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductLicense And Service7,303,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductGrant171,000USD0001601830-26-000078
    Q1 2026Quarterly · 2026-03-31ProductLicense And Service6,301,000USD0001601830-26-000078
    Q4 2025Quarterly · 2025-12-31ProductGrant186,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductLicense And Service35,352,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyOther Countries0USD0001601830-26-000039
    FY 2025Yearly · 2025-12-31GeographyUnited Kingdom35,337,000USD0001601830-26-000039
    FY 2025Yearly · 2025-12-31GeographyUnited States39,344,000USD0001601830-26-000039
    FY 2025Yearly · 2025-12-31ProductGrant425,000USD0001601830-26-000039
    FY 2025Yearly · 2025-12-31ProductLicense And Service74,256,000USD0001601830-26-000039
    Q3 2025Quarterly · 2025-09-30ProductGrant192,000USD0001601830-25-000166
    Q3 2025Quarterly · 2025-09-30ProductLicense And Service4,983,000USD0001601830-25-000166
    Q3 2025Quarterly · 2025-09-30GeographyUnited Kingdom4,065,000USD0001601830-25-000166
    Q3 2025Quarterly · 2025-09-30GeographyUnited States1,110,000USD0001601830-25-000166
    Q2 2025Quarterly · 2025-06-30ProductGrant120,000USD0001601830-25-000127
    Q2 2025Quarterly · 2025-06-30ProductLicense And Service19,103,000USD0001601830-25-000127
    Q1 2025Quarterly · 2025-03-31ProductGrant-73,000USD0001601830-26-000078
    Q1 2025Quarterly · 2025-03-31ProductLicense And Service14,818,000USD0001601830-26-000078
    Q4 2024Quarterly · 2024-12-31ProductGrant35,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductLicense And Service4,511,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyOther Countries327,000USD0001601830-26-000039
    FY 2024Yearly · 2024-12-31GeographyUnited Kingdom1,135,000USD0001601830-26-000039
    FY 2024Yearly · 2024-12-31GeographyUnited States57,377,000USD0001601830-26-000039
    FY 2024Yearly · 2024-12-31ProductGrant351,000USD0001601830-26-000039
    FY 2024Yearly · 2024-12-31ProductLicense And Service58,488,000USD0001601830-26-000039
    Q3 2024Quarterly · 2024-09-30ProductGrant0USD0001601830-25-000166
    Q3 2024Quarterly · 2024-09-30ProductLicense And Service26,082,000USD0001601830-25-000166
    Q3 2024Quarterly · 2024-09-30GeographyUnited Kingdom0USD0001601830-25-000166
    Q3 2024Quarterly · 2024-09-30GeographyUnited States26,082,000USD0001601830-25-000166
    FY 2023Yearly · 2023-12-31GeographyOther Countries769,000USD0001601830-26-000039
    FY 2023Yearly · 2023-12-31GeographyUnited Kingdom0USD0001601830-26-000039
    FY 2023Yearly · 2023-12-31GeographyUnited States43,806,000USD0001601830-26-000039
    FY 2023Yearly · 2023-12-31ProductGrant699,000USD0001601830-26-000039
    FY 2023Yearly · 2023-12-31ProductLicense And Service43,876,000USD0001601830-26-000039
    FY 2022Yearly · 2022-12-31ProductGrant162,000USD0001601830-25-000035
    FY 2022Yearly · 2022-12-31ProductLicense And Service39,681,000USD0001601830-25-000035
    FY 2021Yearly · 2021-12-31ProductGrant178,000USD0001601830-24-000019
    FY 2021Yearly · 2021-12-31ProductLicense And Service10,000,000USD0001601830-24-000019
    FY 2020Yearly · 2020-12-31ProductGrant549,000USD0001601830-23-000010
    FY 2020Yearly · 2020-12-31ProductLicense And Service3,413,000USD0001601830-23-000010
    FY 2019Yearly · 2019-12-31ProductGrant608,000USD0001601830-22-000012
    FY 2019Yearly · 2019-12-31ProductLicense And Service1,711,000USD0001601830-22-000012

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.